Pro-Dex, Inc. (PDEX)
NASDAQ: PDEX · Real-Time Price · USD
59.49
+0.33 (0.55%)
May 19, 2026, 9:57 AM EDT - Market open
Pro-Dex Employees
As of June 30, 2025, Pro-Dex had 181 total employees, including 179 full-time and 2 part-time employees. The number of employees increased by 33 or 22.30% compared to the previous year.
Employees
181
Change (1Y)
33
Growth (1Y)
22.30%
Revenue / Employee
$412,359
Profits / Employee
$66,309
Market Cap
189.92M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Jun 30, 2025 | 181 | 33 | 22.30% | 179 | 2 |
| Jun 30, 2024 | 148 | 2 | 1.37% | 146 | 2 |
| Jun 30, 2023 | 146 | 11 | 8.15% | 145 | 1 |
| Jun 30, 2022 | 135 | 17 | 14.41% | 134 | 1 |
| Jun 30, 2021 | 118 | 1 | 0.85% | 117 | 1 |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Embecta | 1,850 |
| AngioDynamics | 675 |
| OraSure Technologies | 500 |
| Nyxoah | 154 |
| Utah Medical Products | 152 |
| Stereotaxis | 131 |
| Sanara MedTech | 108 |
| KORU Medical Systems | 73 |
PDEX News
- 18 days ago - Pro-Dex, Inc. Announces Fiscal 2026 Third Quarter and Nine Month Results - Accesswire
- 19 days ago - Pro-Dex Quarterly report: Q3 2026 - Filings
- 19 days ago - Pro-Dex Earnings release: Q3 2026 - Filings
- 3 months ago - Pro-Dex, Inc. Announces Acquisition of Advanced Precision Machining - Accesswire
- 3 months ago - Pro-Dex reports Q2 EPS 66c vs. 61c last year - TheFly
- 3 months ago - Pro-Dex, Inc. Announces Fiscal 2026 Second Quarter and Six-Month Results - Accesswire
- 3 months ago - Pro-Dex Earnings release: Q2 2026 - Filings
- 3 months ago - Pro-Dex Quarterly report: Q2 2026 - Filings